TickrTrends LFST fair value analysis

LifeStance Health Group Inc (LFST) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 51/100

gurufocus.com · 2026-09-10

On September 10, 2026, LifeStance Health Group Inc (LFST) shares rose 3.2%, trading at $13.00 within a 52-week range of $4.77 to $13.27. This recent uptick come

TickrTrends take: LFST has moved higher in recent trading, though valuation metrics present a mixed picture for investors focused on intrinsic value assessment. The GF Score of 51 out of 100 suggests the company sits in a middle range for overall quality and financial health within the Healthcare sector. Since TickrTrends is still developing its full valuation framework for LFST, investors awaiting a complete derived verdict may want to monitor whether the stock's recent price movement aligns with fundamental value metrics before drawing conclusions about the overvaluation assessment.

Read the full story at gurufocus.com →

Is LFST undervalued? See TickrTrends' fair value analysis →